BACKGROUND
Since 2018, The Stock Exchange of Hong Kong Limited (the “Stock Exchange”) has introduced and refined its regulatory regime through major listing reforms permitting the listing of biotech companies and weighted voting rights (“WVR”) issuers, and implemented a concessionary secondary listing route for overseas issuers primarily listed on certain qualifying stock exchanges in other jurisdictions. Around 11% of the total number of listings on the Stock Exchange are companies listed under such reforms since first taking effect over four years ago. It has also resulted in a diversification of listed companies in Hong Kong, the information technology industry being by far the largest on the Stock Exchange’s market, having since doubled to 30% as at 31 December 2021 in terms of market capitalisation from 15% prior to 2018, while the market capitalisation of companies in the healthcare industry has now risen steadily to 7% from an insignificant contribution before 2018.
Nevertheless, Hong Kong still lags behind the U.S. and the PRC in terms of the number and market capitalisation of companies in five specialist technology industries, namely (i) next-generation information technology, (ii) advanced hardware, (iii) advanced materials, (iv) new energy and environmental protection and (v) new food and agriculture technologies (the “Specialist Technology Industry(ies)”), as such companies often are not able to meet the financial eligibility (being profit, revenue or cash flow) requirements of the Main Board of the Stock Exchange, despite some having valuations well exceeding the minimum market capitalisation threshold for a Hong Kong listing as well as high growth potential.
In light of this gap in the Hong Kong market, on 19 October 2022, the Stock Exchange published a Consultation Paper – Listing Regime for Specialist Technology Companies (the “Consultation Paper”) to invite feedback from the public on its proposals to expand the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Rule(s)”) to enable the listing of “Specialist Technology Company(ies)” (i.e. a company primarily engaged (whether directly or through its subsidiaries) in the research and development (“R&D”) of, and the commercialisation and/ or sales of product and/ or service within an acceptable sector of a Specialist Technology Industry) on the Main Board. The Stock Exchange encourages interested parties to respond to the Consultation Paper by way of a questionnaire available on http://www.hkex.com.hk by 18 December 2022.
The key proposals regarding the introduction of a listing regime for Specialist Technology Companies are summarised as follows:
KEY PROPOSALS
- Categorisation
The Stock Exchange proposes to divide Specialist Technology Companies into two categories, namely:
- those that have achieved meaningful commercialisation of their product and/or service (alone or together with other products or services) (“Specialist Technology Product(s)”) that applies science and/or technology within an acceptable sector of a Specialist Technology Industry (“Specialist Technology”), by achieving the “Commercialisation Revenue Threshold”, being HK$250 million for the most recent audited financial year deriving from the company’s Specialist Technology business segment (the “Commercial Company(ies)”); and
- those that are primarily engaged in R&D to bring their Specialist Technology Products to commercialisation or have not yet achieved the Commercialisation Revenue Threshold (the “Pre-Commercial Company(ies)”).
Pre-Commercial Companies will entail more stringent requirements for listing owing to heightened risks, including (1) the risk of inability to successfully commercialise their Specialist Technology Products to achieve the Commercialisation Revenue Threshold; (2) risk of corporate failure due to insufficient funding for its operations; and (3) risk of share price volatility and trading illiquidity.
Due to the evolving nature of technology, the Stock Exchange proposes to adopt a broad definition of “Specialist Technology” within the Rules and set out, among others, a non-exhaustive list of acceptable industries and sectors within the definition in a guidance letter (see Appendix V to the Consultation Paper) which will be updated from time to time after consultation with the SFC, taking into account the following principles:
- participants in the relevant sector must have high growth potential;
- success of participants in the sector can be demonstrated to be attributable to the application, their core business, new technologies and/or the application of the relevant science and/or technology within that same sector to a new business model, which also serves to differentiate the participant from traditional market participants serving similar consumers or end users; and
- R&D significantly contributes to the expected value and constitutes a major activity and expense of participants in the sector.
The proposed list of Specialist Technology Industries and acceptable sectors includes:
- Next-generation information technology (e.g. cloud-based services and artificial intelligence);
- Advanced hardware (e.g. robotics and automation, semiconductors, advanced communication and transportation technology, aerospace technology, advanced manufacturing, electric and autonomous vehicles, quantum computing and metaverse technology);
- Advanced materials (e.g. synthetic biological materials, smart glass and nanomaterials);
- New energy and environmental protection (e.g. new energy generation, storage and transmission technology and new green technology); and
- New food and agriculture technologies – (e.g. artificial meat, sustainable protein technology, synthetic biology in food technology, good waste reduction, agricultural biotechnology and crop efficiency technology, agricultural synthetic biology and farming technology).
- Requirements
The table below summarises the key requirements that the Stock Exchange proposes to introduce for the two categories of Specialist Technology Companies:
Subject |
Key requirements |
||||||||||||||||||||
Commercial Company |
Pre-Commercial Company |
||||||||||||||||||||
|
|||||||||||||||||||||
Minimum expected market capitalisation upon listing
|
HK$8 billion (“bn”) |
HK$15 bn |
|||||||||||||||||||
Revenue |
Commercialisation Revenue Threshold
|
No requirement |
|||||||||||||||||||
R&D |
Engaged in R&D for at least three financial years prior to listing |
||||||||||||||||||||
R&D investment constitutes at least 15% of the total operating expenditure for each of the three financial years prior to listing |
R&D investment constitutes at least 50% of the total operating expenditure for each of the three financial years prior to listing |
||||||||||||||||||||
Track record, management and ownership continuity
|
Operation in its current line of business under substantially the same management for at least three financial years prior to listing (a shorter trading record period may be accepted in exceptional circumstances) with ownership continuity for at least 12 months before listing |
||||||||||||||||||||
Third-party investment |
Sophisticated Independent Investors:
Examples of those generally considered by the Stock Exchange as Sophisticated Independent Investors include:
Minimum investment requirements: It must have received meaningful investment from Sophisticated Independent Investors. The following will generally be considered as “meaningful investment”:
|
||||||||||||||||||||
|
|
||||||||||||||||||||
Additional conditions for listing |
Not applicable |
and disclose the above in its listing document
|
|||||||||||||||||||
|
|||||||||||||||||||||
More robust price discovery process |
|
||||||||||||||||||||
Free float and offer size |
|
||||||||||||||||||||
Disclosure(s) in the listing document |
|
||||||||||||||||||||
Not applicable |
Additional disclosure requirements:
|
||||||||||||||||||||
|
|||||||||||||||||||||
Lock-up period |
Ranging from 6 to 12 months |
Ranging from 12 to 24 months |
|||||||||||||||||||
Such lock-up period shall continue irrespective of whether such persons cease to hold their position:
Securities subject to lock-up are those beneficially owned by such shareholder subject to the lock-up restriction as disclosed in the listing document (excluding those sold under an offer for sale contained in the listing document). An existing shareholder holding 10% or more of shares in the company should subscribe for shares in the IPO as a cornerstone investor, in which case the usual lock-up period (generally at least six months) would apply to such cornerstone investment.
Taking into account the significant funding needs of a Specialist Technology Company, the Stock Exchange proposes that any deemed disposal of securities by any of the persons named above during their respective lock-up period as a result of an allotment, grant or issue of new securities shall not be regarded as a breach of the lock-up restrictions, subject to the 6-month restriction period which applies to listed companies under Rule 10.08.
|
|||||||||||||||||||||
Continuing obligations |
Not applicable |
Until the Commercialisation Revenue Threshold is achieved:
|
As with the existing listing regime for biotech companies, the Stock Exchange proposes to allow existing shareholders (including controlling shareholders) of a Specialist Technology Company to participate in its IPO, provided that the requirements for a minimum public float, minimum free float and minimum allocation to independent Institutional Professional Investors be complied with. As such, “Existing Shareholder Conditions” referred to in paragraph 4.20 of the Guidance Letter HKEX-GL85-16 would not apply to a Specialist Technology Company, and any allocations made to core connected persons will typically be granted by the Stock Exchange, subject to a Rule 9.09 waiver having been applied for by the company.
The existing requirements for listing of a company with a WVR structure shall remain unchanged, and Specialist Technology Companies applying to list with a WVR structure shall also comply with the requirements under the Rules relating to WVR.
No change is currently proposed to the scope of sponsors’ duties in the context of the listing of Specialist Technology Companies. Sponsors are required to adhere to the standard of conduct as set out in Practice Note 21 of the Rules and paragraph 17 of the Code of Conduct for Persons Licensed by or Registered with the SFC when carrying out its due diligence.
For further details, please refer to the Consultation Paper published by the Stock Exchange on http://www.hkex.com.hk.
关于本行
何韦律师行是一所香港独立律师行,其律师经验丰富,具创造性及前瞻性思维。
我们的主要业务领域包括:医疗疏忽及医护;企业/商业事务及企业融资;商事及海事争议解决;保险、人身伤害及专业弥偿保险;雇佣;家庭及婚姻;物业及建筑物管理;银行业务;欺诈行为;不良债务;金融服务/企业监管及合规事宜。
作为一家独立的律师行,我们能将法律和商业上利益冲突的情况减至最低,为各行各业的客户处理各种法律事务。本行合伙人在香港发展事业多年,对国际业务及亚洲地区业务有深刻的了解。
免责声明: 本电邮所载数据及任何附件仅提供作就参考用途,并不旨在提供法律意见。如阁下有任何疑问,请电邮至[email protected]。